Press Room

Researchers find Ebola virus in patient’s eye fluid weeks after it was undetectable in blood - 5/7/2015
Researchers gave the first public presentation at the ARVO 2015 Annual Meeting of a case study in which viable Ebola virus was present in the eye's aqueous humor - the clear fluid in the front of the eye, between the lens and the cornea - 10 weeks after the virus was no longer detectable in the patient's blood.

Implant may eliminate need for eye drops after cataract surgery - 5/7/2015
Researchers have developed a drug-releasing implant that controls pain and inflammation, eliminating the need for eye drops following cataract surgery. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

FDA-approved drug may prevent vision lossf - 5/7/2015
An FDA-approved oral medication, 4-phenylbutyrate (PBA), has been found to prevent vision loss in mice with Leber’s congenital amaurosis (LCA). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Emerging technique gives snapshot of an individual eye cell’s health - 5/7/2015
Researchers are studying ways to get a snapshot of all the genetic material that a single retina cell uses to make proteins, revealing the health of that eye cell. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

New treatment may stop progression of eye disease in teens eye cell’s health - 5/7/2015
Doctors have developed a new treatment capable of halting the progression of keratoconus, a progressive eye disease that manifests in teenagers. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Mobile app helps screen for strabismus - 5/6/2015
Researchers have developed a mobile app to quickly and conveniently evaluate people for strabismus, a condition involving misalignment of the eyes. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Herbal supplement may successfully treat glaucoma - 5/6/2015
Scientists have found that baicalein significantly lowers eye pressure and may act as an all-natural treatment for glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Preterm babies with ROP treated with growth inhibitor score lower than those treated with laser treatment - 5/6/2015
Preterm babies with retinopathy of prematurity (ROP) treated using bevacizumab, a growth inhibitor, have been found to have lower motor scores than babies treated with traditional laser ablation. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Nurses help more patients receive treatment for AMD - 5/6/2015
Nurses trained to deliver eye injections for patients with the wet form of age-related macular degeneration (AMD) administered the treatments as safely and effectively as doctors, according to a new study. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

New computer model describes cholesterol in the retina during AMD - 5/6/2015
Researchers have developed a new computer model to describe how cholesterol deposits, known as drusen, behave in the retina in the dry form of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Emerging trends and hot topics: Presented Wednesday, May 6 at the ARVO Annual Meeting - 5/6/2015
In their own words, First Authors at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings. Their abstracts were designated as some of the newest and most innovative research presented on Wednesday, May 6.

Emerging trends and hot topics: Presented Tuesday, May 5 at the ARVO Annual Meeting - 5/5/2015
In their own words, First Authors at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings. Their abstracts were designated as some of the newest and most innovative research presented on Tuesday, May 5.

New target identified for treating glaucoma - 5/5/2015
Researchers have identified a new target for stopping the progressive death of cells in the eye that leads to vision loss in glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Parkinson’s treatment may protect against AMD - 5/5/2015
L-DOPA, a routine drug taken by patients suffering from Parkinson’s disease, has been found to delay the onset of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Scientists develop 3D retinal tissue from stem cells using cGMP - 5/5/2015
Scientists have produced crude 3D tissue structures from induced pluripotent stem (iPS) cells under current good manufacturing practices (cGMP), an important step for eventual large-scale use in human patients. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

New glaucoma research may prevent toxins from spreading, save vision - 5/5/2015
Researchers have found that blocking the connections between cells in the retina can prevent toxins in one cell from spreading – and killing – its neighbors. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Researchers Uncover Target for Treating Diabetic Retinopathy - 5/4/2015
Paving the way for drug discovery efforts, researchers have found a target that – when inhibited – reduces inflammation associated with vision loss in patients with diabetic retinopathy (DR). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Eye drops may be as effective as eye injections for treating wet AMD - 5/4/2015
A new study found that eye drops were just as effective as eye injections for treating the wet form of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Low oxygen in the eye may lead to protein sorting errors that impair vision - 5/4/2015
A new study finds that when cells in the eye do not have enough oxygen, they improperly sort proteins, an issue that has been implicated in age-related macular degeneration (AMD) and Alzheimer’s disease. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

New biomarkers may shorten year-long diagnosis to days - 5/4/2015
Scientists have identified new biomarkers that could distinguish Sjögren’s Syndrome (SS) from other autoimmune diseases in days or weeks, improving on a current time to diagnosis of four-plus years. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

12Next
Advertisement
Charles River ocular research